Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)
0.0913
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 18th, 5:26 AM EST
Detailed Quote
| Previous Close | 0.0913 |
|---|---|
| Open | - |
| Bid | 0.1197 |
| Ask | 0.1199 |
| Day's Range | N/A - N/A |
| 52 Week Range | 0.0880 - 9.860 |
| Volume | 22,781,617 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 46,119,197 |
Chart
News & Press Releases
Via Benzinga · November 17, 2025
Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · November 14, 2025
Which stocks have an unusual volume on Friday?
Via Chartmill · November 14, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via Chartmill · November 14, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · November 14, 2025
Via Benzinga · November 14, 2025
Via Benzinga · November 14, 2025
Via Benzinga · November 13, 2025
Volume analysis on 2025-11-12: stocks with an unusual volume in today's session.
Via Chartmill · November 12, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · November 12, 2025
Via Benzinga · November 12, 2025
Via Benzinga · November 12, 2025
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · November 11, 2025
Via Benzinga · November 11, 2025
Via Benzinga · November 11, 2025
Via Benzinga · November 11, 2025
Via Benzinga · November 10, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · November 10, 2025
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade show, the world's largest pharmaceutical event. The Company engaged in numerous strategic discussions with global pharmaceutical companies regarding technical collaboration and licensing opportunities for its lead product candidate, a novel sublingual high-dose aspirin.
Via ACCESS Newswire · November 6, 2025
Via Benzinga · October 28, 2025
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery technology. This application - which seeks patent protection of Aspire's proprietary technology in a variety of classes of drugs and other substances--focuses exclusively on protecting the Company's advanced sublingual drug delivery system, which is designed to enhance the pharmacokinetic performance of Active Pharmaceutical Ingredients ("APIs") and other substances into the bloodstream, increasing bioavailability and improving speed of onset.
Via ACCESS Newswire · October 6, 2025
Showcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual Aspirin
Via ACCESS Newswire · October 3, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 3, 2025
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via Chartmill · October 3, 2025
Via Benzinga · October 3, 2025